Anti-tumor activity and the mechanism of SIP-S: A sulfated polysaccharide with anti-metastatic effect

被引:34
作者
Zong, Aizhen [1 ,5 ]
Liu, Yuhong [2 ]
Zhang, Yan [1 ]
Song, Xinlei [1 ]
Shi, Yikang [3 ]
Cao, Hongzhi [3 ]
Liu, Chunhui [1 ,3 ]
Cheng, Yanna [4 ]
Jiang, Wenjie [1 ]
Du, Fangling [5 ]
Wang, Fengshan [1 ,3 ]
机构
[1] Shandong Univ, Inst Biochem & Biotechnol Drugs, Sch Pharmaceut Sci, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Sch Pharmaceut Sci, Jinan 250355, Shandong, Peoples R China
[3] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250012, Shandong, Peoples R China
[4] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China
[5] Shandong Acad Agr Sci, Inst Agrofood Sci Technol, Jinan 250100, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
SIP-S; Cyclophosphamide; Anti-tumor activity; Immunoenhancing activity; Apoptosis; SEPIELLA-MAINDRONI INK; CANCER; IMMUNOMODULATION; APOPTOSIS;
D O I
10.1016/j.carbpol.2015.04.017
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Our previous studies demonstrated that SIP-S had anti-metastatic activity and inhibited the growth of metastatic foci. Here we report the anti-tumor and immunoregulatory potential of SIP-S. SIP-S could significantly inhibit tumor growth in S180-bearing mice, and the inhibition rates was 43.7% at 30 mg/kg d. Besides, SIP-S could improve the thymus and spleen indices of S180-bearing mice and the mice treated with CTX. The combination of SIP-S (15 mg/kg d) with CTX (12.5 mg/kg d) showed higher anti-tumor potency than CTX (25 mg/kg d) alone. These results indicated that SIP-S had immunoenhancing and anticancer activity, and the immunoenhancing activity might be one mechanism for its anti-tumor activity. Flow cytometry results showed that SIP-S could induce tumor cells apoptosis. Western blot analysis indicated that SIP-S could upregulate the expression of pro-apoptotic proteins, caspase-3, -8, -9 and Bax, and downregulate the expression of anti-apoptotic protein PARP-1 in tumor cells in a dose-dependent manner. In summary, SIP-S has anti-tumor activity, which may be associated with its immunostimulating and pro-apoptotic activity. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 19 条
[1]   CD73: a potent suppressor of antitumor immune responses [J].
Beavis, Paul. A. ;
Stagg, John ;
Darcy, Phillip K. ;
Smyth, Mark J. .
TRENDS IN IMMUNOLOGY, 2012, 33 (05) :231-237
[2]  
Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8
[3]   Apoptosis and non-apoptotic deaths in cancer development and treatment response [J].
de Bruin, Elza C. ;
Mederna, Jan Paul .
CANCER TREATMENT REVIEWS, 2008, 34 (08) :737-749
[4]   PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia [J].
Diamantopoulos, Panagiotis T. ;
Papadopoulou, Vasiliki ;
Polonyfi, Katerina ;
Iliakis, Theodoros ;
Viniou, Nora-Athina .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[5]   Immunomodulation in cancer therapeutics [J].
Ehrke, MJ .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (08) :1105-1119
[6]   Sulfation of extracellular polysaccharides of red microalgae: preparation, characterization and properties [J].
Geresh, S ;
Mamontov, A ;
Weinstein, J .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2002, 50 (2-3) :179-187
[7]   RETRACTED: Apoptosis and Molecular Targeting Therapy in Cancer (Retracted Article) [J].
Hassan, Mohamed ;
Watari, Hidemichi ;
AbuAlmaaty, Ali ;
Ohba, Yusuke ;
Sakuragi, Noriaki .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[8]   Structural characterisation and antimutagenic activity of a novel polysaccharide isolated from Sepiella maindroni ink [J].
Liu, Chunhui ;
Li, Xiaodong ;
Li, Yuhua ;
Feng, You ;
Zhou, Shuai ;
Wang, Fengshan .
FOOD CHEMISTRY, 2008, 110 (04) :807-813
[9]   Combinations of anticancer drugs and immunotherapy [J].
Mitchell, MS .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (11) :686-692
[10]   Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential [J].
Schepetkin, IA ;
Quinn, MT .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (03) :317-333